Hyppigheden af forhøjede ALT- niveauer under behandling i de to behandlingsgrupper ifølge AASLD (American Association for the Study of Liver Diseases) definition (ALT- stigning > 2x udgangsværdi og > 10x ULN) er yderligere beskrevet i tabel 3 herunder.
The incidence of on treatment alanine aminotransferase (ALT) flares in the two treatment arms according to AASLD (American Association for the Study of Liver Diseases) definition (ALT elevation > 2x baseline and > 10x ULN) are further described in Table 3 below.